Apixaban or Vitamin K Antagonists for Stroke Prevention in Patients With Atrial Fibrillation on Hemodialysis: Results of the Randomized Axadia-AFNET 8 Trial

被引：0
|
作者：
Reinecke, Holger [1 ]
Bauersachs, Rupert [2 ]
Breithardt, Gunter [3 ]
Engelbertz, Christiane [3 ]
Gerss, Joachim [4 ]
Gaerlich, Dennis [4 ]
Juergensmeyer, Sabine [5 ]
Wanner, Christoph [6 ]
Kirchhof, Paulus [7 ]
机构：
[1] Univ Hosp Muenster, Dept Cardiol, Munster, Germany
[2] Agaples Bethanien Hosp, Med Care Cntr, Frankfurt, Germany
[3] Univ Hosp Muenster, Dept Cardiol, Munster, Germany
[4] Univ Munster, Inst Biostat & Clin Rsch, Munster, Germany
[5] Atrial Fibrillat Network, Munster, Germany
[6] Univ Hosp, Div Nephrol, Dept Med, Wurzburg, Germany
[7] Univ Hosp Hamburg Eppendorf, Dept Cardiol, Hamburg, Germany
来源：
CIRCULATION | 2022年 / 146卷 / 25期
关键词：
atrialfibrillation; apixaban; vitamin K antagonist; hemodialysis; randomized; controlled trial; stroke prevention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18519
引用
收藏
页码：E589 / E590
页数：2
相关论文
共 50 条
  • [41] Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry
    Haeusler, Karl Georg
    Gerth, Andrea
    Limbourg, Tobias
    Tebbe, Ulrich
    Oeff, Michael
    Wegscheider, Karl
    Treszl, Andras
    Ravens, Ursula
    Meinertz, Thomas
    Kirchhof, Paulus
    Breithardt, Guenter
    Steinbeck, Gerhard
    Nabauer, Michael
    BMC NEUROLOGY, 2015, 15
  • [42] Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation - A Randomized trial
    Albers, GW
    Diener, HC
    Frison, L
    Grind, M
    Nevinson, M
    Partridge, S
    Halperin, JL
    Horrow, J
    Olsson, SB
    Petersen, P
    Vahanian, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06): : 690 - 698
  • [43] New Oral Anticoagulant Versus Vitamin K Antagonists for Thoracoscopic Ablation in Patients With Persistent Atrial Fibrillation: A Randomized Controlled Trial
    Lee, Yoonseo
    Jeong, Dong Seop
    Ahn, Joonghyun
    Park, Kyoung-Min
    Park, Seung-Jung
    Kim, June Soo
    On, Young Keun
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2023, 35 (02) : 268 - 274
  • [44] Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
    Giorgi, Mariano Anibal
    Caroli, Christian
    Giglio, Norberto Damian
    Micone, Paula
    Aiello, Eleonora
    Vulcano, Cristina
    Blanco, Julia
    Donato, Bonnie
    Quevedo, Joaquin Mould
    HEALTH ECONOMICS REVIEW, 2015, 5
  • [45] Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
    Mariano Anibal Giorgi
    Christian Caroli
    Norberto Damian Giglio
    Paula Micone
    Eleonora Aiello
    Cristina Vulcano
    Julia Blanco
    Bonnie Donato
    Joaquin Mould Quevedo
    Health Economics Review, 5
  • [46] Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study
    Lena M. Paschke
    Kerstin Klimke
    Attila Altiner
    Dominik von Stillfried
    Maike Schulz
    BMC Medicine, 18
  • [47] Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study
    Paschke, Lena M.
    Klimke, Kerstin
    Altiner, Attila
    von Stillfried, Dominik
    Schulz, Maike
    BMC MEDICINE, 2020, 18 (01)
  • [48] Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
    De Vriese, An S.
    Caluwe, Rogier
    Pyfferoen, Lotte
    De Bacquer, Dirk
    De Boeck, Koen
    Delanote, Joost
    De Surgeloose, Didier
    Van Hoenacker, Piet
    Van Vlem, Bruno
    Verbeke, Francis
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (01): : 186 - 196
  • [49] Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation
    Ukaigwe, Anene
    Shrestha, Pragya
    Karmacharya, Paras
    Hussain, Sarah K.
    Samii, Soraya
    Gonzalez, Mario D.
    Wolbrette, Deborah
    Naccarrelli, Gerald V.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2017, 48 (02) : 223 - 233
  • [50] Letter by Vazquez et al Regarding Article, "Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial"
    Vazquez, Eduardo
    Vazquez-Sanchez, Teresa
    Sanchez-Perales, Carmen
    CIRCULATION, 2023, 148 (04) : 378 - 378
12345